tirzepatide phase 2 Tirzepatide: A First-in-class Twincretin for the Management of Type Diabetes Apitegromab for lean mass preservation

Overall, postdiscontinuation trajectories likely reflect more than biological rebound, although the relative contribution of psychological and behavioral factors remains insufficiently studied in the context of GLP-1 RA therapy

This slow adjustment helps the body handle side effects better before moving to higher doses

doi: 10.1016/j.jnutbio.2022.109067 85 LiJWuDZhangSWuYBiXZhouYet al

Theranostic nanoparticles Notably, the application of nanoparticles in MRI imaging has transcended mere diagnosis and is evolving toward theranostics [96]

It is also possible that some people drink less because they are intentionally trying to support weight loss, improve blood sugar, sleep better, or avoid side effects